Moderna Filles for Emergency Use Authorization From the FDA for Its Vaccine Candidate
Publisher |
iHeartPodcasts
Media Type |
audio
Categories Via RSS |
Health & Fitness
Publication Date |
Dec 01, 2020
Episode Duration |
00:06:24

Moderna has now become the second company to request emergency use authorization from the FDA for their vaccine candidate. In their latest findings, the vaccine is over 94% effective against coronavirus and very effective at preventing serious cases of the virus. The next step will be on Dec. 10 when the FDA will discuss approval for Pfizer and then Dec. 17 for Moderna. Karen Weintraub, health reporter at USA Today, joins us for more as we get closer to vaccine approvals.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review